You are here: Home » News-CM » Companies » Results
Business Standard

Rubra Medicaments reports standalone net profit of Rs 0.05 crore in the June 2017 quarter

Capital Market 

Sales rise 1214.29% to Rs 0.92 crore

Net profit of reported to Rs 0.05 crore in the quarter ended June 2017. There were no net profit/loss reported during the previous quarter ended June 2016. Sales rose 1214.29% to Rs 0.92 crore in the quarter ended June 2017 as against Rs 0.07 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales0.920.07 1214 OPM %-2.170 -PBDT0.050 0 PBT0.050 0 NP0.050 0

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU